Drug shortage: Clindamycin Phosphate Injection (CLEOCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN IN 5 PERCENT DEXTROSE)
FDA lists 23 presentations as Current. Availability: Unavailable (4), Limited Availability (3), Available (10). Reason: Discontinuation of the manufacture of the drug; Other. Companies: Sagent Pharmaceuticals, Pfizer Inc., Baxter Healthcare, Sandoz Inc..
- Published by source
- 2023-03-21
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Sagent Pharmaceuticals
- Products
- Clindamycin Phosphate Injection CLEOCIN PHOSPHATE CLINDAMYCIN PHOSPHATE CLINDAMYCIN IN 5 PERCENT DEXTROSE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Selling through remaining short-dated inventory (Dec 2026).
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-03-21
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #899 | new | 2026-10-22 | 61657936fdd9…f44c93 | 5fe09c8bb2c4…994d09 |
Chain head: #1094 edf3be25ec2e…478842